TrialDiabetes, obesity & metabolism2020

Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase-4 inhibitor Linagliptin: A subanalysis from a randomized, placebo-controlled trial (RELEASE study).

Stefanie A de Boer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.